Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
for
HR+ HER2- Breast Cancer
Location: Lone Tree CO, Austin TX, San Antonio TX, Los Angeles CA,
Sponsor: Faeth Therapeutics
Sex: All
Age: 18+
Code: NCT07558733
Phase 1, Phase 2, Recruiting
Active & Responsive
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
for
Knee Cartilage Defects
Location: Parker CO, Steamboat Springs CO, Salt Lake City UT,
Sponsor: Medipost, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07339111
Phase 3, Recruiting
Active & Responsive
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for
Post Traumatic Stress Disorder
Location: Evergreen CO, Orem UT, Draper UT, El Paso TX,
Sponsor: Transcend Therapeutics
Sex: All
Age: 18+
Code: NCT07456696
Phase 3, Recruiting
Active & Responsive
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
for
Post Procedural Erythema
Location: Boulder CO, Dallas TX, Tyler TX, Fresno CA,
Sponsor: Acorn Biolabs Inc.
Sex: All
Age: 18+
Code: NCT06477172
Recruiting
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
for
Idiopathic Hypersomnia
Location: Boulder CO, Colorado Springs CO, Ardmore OK, Peoria AZ,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07500090
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
for
EDS, Cataplexy, Fatigue, Narcolepsy
Location: Boulder CO, Colorado Springs CO, Peoria AZ, Dallas TX,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07675135
Phase 3, Recruiting
Active & Responsive
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
for
Pain
Location: Longmont CO, Salt Lake City UT, Tulsa OK, Phoenix AZ,
Sponsor: Adneuris Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07845071
Phase 3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Longmont CO, Salt Lake City UT, Wichita KS, Omaha NE,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Greeley CO, Loveland CO, Fort Collins CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase 2, Phase 3, Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: Greeley CO, Minneota MN, Reno NV, Spokane Valley WA,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase 3, Recruiting
Active & Responsive
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
for
Emphysema, Pulmonary, Emphysema or COPD
Location: Loveland CO, Phoenix AZ, Dallas TX, Peoria IL,
Sponsor: Pulmonx Corporation
Sex: All
Age: 40 - 70+
Code: NCT06035120
Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Loveland CO, Wichita KS, Oklahoma City OK,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Fort Collins CO, Colorado Springs CO, Scottsdale AZ,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
Active & Responsive
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Fort Collins CO, Albuquerque NM, Peoria AZ,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07290036
Phase 1, Recruiting
Active & Responsive
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Colorado Springs CO, Overland Park KS, Tucson AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT06338995
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
for
Asthma
Location: Colorado Springs CO, Oklahoma City OK, Edmond OK,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06977581
Phase 2, Recruiting
Active & Responsive
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Colorado Springs CO, St Louis MO, San Antonio TX,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06812078
Phase 2, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer